Gossamer bio q1 loss per share $0.87

Gossamer bio announces first quarter 2020 financial results and provides corporate update.q1 loss per share $0.87.q1 earnings per share estimate $-0.80 -- refinitiv ibes data.cash, cash equivalents and marketable securities as of march 31, 2020, were $346.2 million.gossamer bio - expects current cash and access to debt facility will be sufficient to fund its operating and capital expenditures to mid-2022.
GOSS Ratings Summary
GOSS Quant Ranking